{"count": 2, "results": [{"_id": "28294379", "pmid": 28294379, "title": "Use of oral antidiabetic agents and risk of community-acquired pneumonia: a nested case-control study.", "journal": "Br J Clin Pharmacol", "authors": ["Gorricho J", "Garjón J", "Alonso A", "Celaya MC", "Saiz LC", "Erviti J", "López A"], "date": "2017-09-01T00:00:00Z", "doi": "10.1111/bcp.13288", "meta_date_publication": "2017 Sep", "meta_volume": "83", "meta_issue": "9", "meta_pages": "2034-2044", "score": 50060.3, "text_hl": "RESULTS: From a cohort of 76 009 T2DM @SPECIES_9606 @@@patients@@@, we identified 1803 cases of @<m>DISEASE_Communication_Disorders</m> @DISEASE_MESH:D003147 @@@CAP@@@. No difference in the incidence of @<m>DISEASE_Communication_Disorders</m> @DISEASE_MESH:D003147 @@@CAP@@@ was observed when comparing any OAD in monotherapy with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Gorricho J, Garjón J, Alonso A, Celaya MC, Saiz LC, Erviti J, López A. Use of oral antidiabetic agents and risk of community-acquired pneumonia: a nested case-control study. Br J Clin Pharmacol. 2017 Sep;83(9):2034-2044. PMID: 28294379", "BibTeX": "@article{28294379, title={Use of oral antidiabetic agents and risk of community-acquired pneumonia: a nested case-control study.}, author={Gorricho J and Garjón J and Alonso A and Celaya MC and Saiz LC and Erviti J and López A}, journal={Br J Clin Pharmacol}, volume={83}, number={9}, pages={2034-2044}}"}}, {"_id": "19496972", "pmid": 19496972, "title": "Metformin therapy to reduce weight gain and visceral adiposity in children and adolescents with neurogenic or myogenic motor deficit.", "journal": "Pediatr Diabetes", "authors": ["Casteels K", "Fieuws S", "van Helvoirt M", "Verpoorten C", "Goemans N", "Coudyzer W", "Loeckx D", "de Zegher F"], "date": "2010-02-01T00:00:00Z", "doi": "10.1111/j.1399-5448.2009.00512.x", "meta_date_publication": "2010 Feb", "meta_volume": "11", "meta_issue": "1", "meta_pages": "61-9", "score": 50057.12, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ therapy to reduce @DISEASE_Weight_Gain @DISEASE_MESH:D015430 @@@weight gain@@@ and @DISEASE_Intestinal_Pseudo_Obstruction @DISEASE_MESH:D007418 @@@visceral adiposity@@@ in children and adolescents with @<m>DISEASE_Communication_Disorders</m> @DISEASE_MESH:D003147 @@@neurogenic or myogenic motor deficit@@@.", "citations": {"NLM": "Casteels K, Fieuws S, van Helvoirt M, Verpoorten C, Goemans N, Coudyzer W, Loeckx D, de Zegher F. Metformin therapy to reduce weight gain and visceral adiposity in children and adolescents with neurogenic or myogenic motor deficit. Pediatr Diabetes. 2010 Feb;11(1):61-9. PMID: 19496972", "BibTeX": "@article{19496972, title={Metformin therapy to reduce weight gain and visceral adiposity in children and adolescents with neurogenic or myogenic motor deficit.}, author={Casteels K and Fieuws S and van Helvoirt M and Verpoorten C and Goemans N and Coudyzer W and Loeckx D and de Zegher F}, journal={Pediatr Diabetes}, volume={11}, number={1}, pages={61-9}}"}}]}